No Immune Risk Profile among individuals who reach 100 years of age: findings from the Swedish NONA immune longitudinal study
- PMID: 17606347
- DOI: 10.1016/j.exger.2007.05.001
No Immune Risk Profile among individuals who reach 100 years of age: findings from the Swedish NONA immune longitudinal study
Abstract
In the present NONA immune longitudinal study, we investigate the previously identified Immune Risk Profile (IRP), defined by an inverted CD4/CD8 ratio and associated with persistent cytomegalovirus infection and increased numbers of CD8+CD28- cells, relative 6-year survival and age in NONA individuals. These subjects have now reached age 92, 96, and for the first time in this study, 100 years at follow-up. A 55 year old middle-aged group was used for comparison. Immunological monitoring included the analysis of numbers of lymphocytes and neutrophils, the T-cell subsets CD3+CD4+, CD3+CD8+, CD8+CD28+, CD8+CD28-, and the CD4/CD8 ratio. Longitudinal data were analysed by multivariate analyses of variance (MANOVA) from four measurement occasions at 2-year inter-intervals. One-way ANOVA was used for cross-sectional comparisons at baseline and the 6-year follow-up. The results confirmed the importance of the IRP as a major predictor of mortality in this population of very old. Moreover, the results suggested that survival to the age of 100 years is associated with selection of individuals with an "inverted" IRP that was stable across time, i.e., maintenance of a high CD4/CD8 ratio and low numbers of CD8+CD28- cells. The results underlines the importance of a longitudinal study design in dissecting immune parameters predictive of survival and show for the first time that centenarian status is associated with avoidance of the IRP over at least the previous 6 years and probably throughout life.
Similar articles
-
The immune risk profile is associated with age and gender: findings from three Swedish population studies of individuals 20-100 years of age.Biogerontology. 2008 Oct;9(5):299-308. doi: 10.1007/s10522-008-9138-6. Epub 2008 Mar 28. Biogerontology. 2008. PMID: 18369735
-
The immune risk phenotype is associated with IL-6 in the terminal decline stage: findings from the Swedish NONA immune longitudinal study of very late life functioning.Mech Ageing Dev. 2006 Aug;127(8):695-704. doi: 10.1016/j.mad.2006.04.003. Epub 2006 Jun 5. Mech Ageing Dev. 2006. PMID: 16750842
-
Cytomegalovirus and human immunosenescence.Rev Med Virol. 2009 Jan;19(1):47-56. doi: 10.1002/rmv.598. Rev Med Virol. 2009. PMID: 19035529 Review.
-
Reference values for CD4+ and CD8+ T lymphocytes with naïve or memory phenotype and their association with mortality in the elderly.Gerontology. 2009;55(3):314-21. doi: 10.1159/000199451. Epub 2009 Feb 4. Gerontology. 2009. PMID: 19190395
-
The immune system in extreme longevity.Exp Gerontol. 2008 Feb;43(2):61-5. doi: 10.1016/j.exger.2007.06.008. Epub 2007 Jul 4. Exp Gerontol. 2008. PMID: 17870272 Review.
Cited by
-
Intersecting Pathways: The Role of Metabolic Dysregulation, Gastrointestinal Microbiome, and Inflammation in Acute Ischemic Stroke Pathogenesis and Outcomes.J Clin Med. 2024 Jul 21;13(14):4258. doi: 10.3390/jcm13144258. J Clin Med. 2024. PMID: 39064298 Free PMC article. Review.
-
Systemic inflammation in relation to exceptional memory in the Long Life Family Study (LLFS).Brain Behav Immun Health. 2024 Feb 23;37:100746. doi: 10.1016/j.bbih.2024.100746. eCollection 2024 May. Brain Behav Immun Health. 2024. PMID: 38476338 Free PMC article.
-
A case of vitiligo after COVID-19 vaccination: a possible role of thymic dysfunction.J Zhejiang Univ Sci B. 2023 Dec 15;24(12):1141-1150. doi: 10.1631/jzus.B2300025. J Zhejiang Univ Sci B. 2023. PMID: 38057270 Free PMC article.
-
Immunosenescence and inflammatory markers in Cuban centenarians: implications for survival.Aging Clin Exp Res. 2023 Nov;35(11):2839-2842. doi: 10.1007/s40520-023-02567-9. Epub 2023 Oct 12. Aging Clin Exp Res. 2023. PMID: 37821691
-
Activation of telomerase by TA-65 enhances immunity and reduces inflammation post myocardial infarction.Geroscience. 2023 Aug;45(4):2689-2705. doi: 10.1007/s11357-023-00794-6. Epub 2023 Apr 22. Geroscience. 2023. PMID: 37086366 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials